Coping with amyotrophic lateral sclerosis; from diagnosis and during disease progression

被引:21
|
作者
Larsson, Birgitta Jakobsson [1 ]
Nordin, Karin [2 ]
Nygren, Ingela [1 ]
机构
[1] Uppsala Univ, Dept Neurosci, Neurol, S-75105 Uppsala, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75105 Uppsala, Sweden
关键词
ALS; Coping strategies; Physical function; Emotional well-being; Prospective; Longitudinal; MOTOR-NEURON DISEASE; HOSPITAL ANXIETY; DEPRESSION SCALE; STRATEGIES; ALS; EXPERIENCES; LIFE; VALIDATION; MANAGEMENT; PEOPLE;
D O I
10.1016/j.jns.2015.12.042
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To evaluate coping strategies among patients with Amyotrophic lateral sclerosis starting with diagnosis and during the disease progression, as well as investigate changes and correlations between coping strategies, emotional well-being and physical function. A total of 36 patients participated in the study. The patients filled out the Hospital Anxiety and Depression Scale and the Motor Neuron Disease Coping Scale. Physical function was measured using the revised ALS functional rating scale. Data were collected regularly from diagnosis and over a two years period. As a way to cope with the disease patients relied on both problem focused and emotional focused strategies. The use of coping strategies remained stable. Both physical disabilities and emotional well-being was related to some coping strategies, with some variation during the disease progression. Moreover, some coping strategies were related to symptoms of anxiety and depression. Irrespective of whether the coping strategies affect the emotional well-being or vice versa, the results show the importance of early and continuous evaluation of coping and emotional well-being to ease the emotional distress and provide support to the patient so that he/she can cope with the disease during the disease progression. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 50 条
  • [41] Association of autonomic dysfunction with disease progression and survival in Amyotrophic Lateral Sclerosis
    Dubbioso, R.
    Provitera, V.
    Pacella, D.
    Santoro, L.
    Manganelli, F.
    Nolano, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 127 - 127
  • [42] Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
    Dreger, Marie
    Steinbach, Robert
    Otto, Markus
    Turner, Martin R.
    Grosskreutz, Julian
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (04): : 422 - 435
  • [43] C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression
    Wells, Tyler L.
    Myles, Jacob R.
    Akay, Turgay
    [J]. JOURNAL OF NEUROSCIENCE, 2021, 41 (38): : 8088 - 8101
  • [44] Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid
    Raman, C
    McAllister, SD
    Rizvi, G
    Patel, SG
    Moore, DH
    Abood, ME
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2004, 5 (01): : 33 - 39
  • [45] The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
    Kelly, Madeline
    Lavrov, Arseniy
    Garcia-Gancedo, Luis
    Parr, Jim
    Hart, Robert
    Chiwera, Theresa
    Shaw, Christopher E.
    Al-Chalabi, Ammar
    Marsden, Rachael
    Turner, Martin R.
    Talbot, Kevin
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (7-8) : 563 - 573
  • [46] Deep learning methods to predict amyotrophic lateral sclerosis disease progression
    Corrado Pancotti
    Giovanni Birolo
    Cesare Rollo
    Tiziana Sanavia
    Barbara Di Camillo
    Umberto Manera
    Adriano Chiò
    Piero Fariselli
    [J]. Scientific Reports, 12
  • [47] RATE OF AMYOTROPHIC LATERAL SCLEROSIS DISEASE PROGRESSION - AN EXAMPLE OF REGRESSION TO THE MEAN
    MAIN, DW
    DORSEY, FC
    [J]. CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 272 - 272
  • [48] Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis
    Spinelli, Edoardo G.
    Riva, Nilo
    Rancoita, Paola M., V
    Schito, Paride
    Doretti, Alberto
    Poletti, Barbara
    Di Serio, Clelia
    Silani, Vincenzo
    Filippi, Massimo
    Agosta, Federica
    [J]. NEUROIMAGE-CLINICAL, 2020, 27
  • [49] A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis
    Kobayakawa, Yuko
    Todaka, Koji
    Hashimoto, Yu
    Ko, Senri
    Shiraishi, Wataru
    Kishimoto, Junji
    Kira, Jun-ichi
    Yamasaki, Ryo
    Isobe, Noriko
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 442
  • [50] Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
    Zhang, Yong-guo
    Wu, Shaoping
    Yi, Jianxun
    Xia, Yinglin
    Jin, Dapeng
    Zhou, Jingsong
    Sun, Jun
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (02) : 322 - 336